Princess Margaret Cancer Centre ( Site 0003)

Toronto, Ontario M5G 2M9

1 studies enrolling now · 2 studies all time

What they study most

Bladder Cancer, Non-Muscle Invasive Bladder Cancer

Studies at this site

• A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) — Recruiting now
• A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) — Running, not enrolling